Equities

HitGen Inc

688222:SHH

HitGen Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)13.08
  • Today's Change0.04 / 0.31%
  • Shares traded3.19m
  • 1 Year change-17.06%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HitGen Inc is a China-based company mainly engaged in the early research and development of original innovative drugs. The Company focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The Company mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The Company conducts its businesses within the domestic market and to overseas markets.

  • Revenue in CNY (TTM)409.13m
  • Net income in CNY64.05m
  • Incorporated2012
  • Employees452.00
  • Location
    HitGen IncBlock 6,No.8 Huigu East 1st Road, Tianfu InternaCHENGDU 610200ChinaCHN
  • Phone+86 2 885197385
  • Fax+86 2 883310298
  • Websitehttps://www.hitgen.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jiangsu Jibeier Pharmaceutical Co Ltd889.82m233.59m5.08bn1.45k21.602.59--5.711.241.244.7410.370.4263.135.33615,794.8011.179.7712.0610.6687.8788.4426.2223.296.76--0.00530.6831.4912.1641.6517.79112.78--
Beijing Kawin Technol Sha-hld Co Ltd1.43bn117.53m5.16bn584.0042.762.85--3.600.70610.70618.6110.600.62641.664.422,451,945.006.115.317.696.7682.3586.029.768.103.25--0.080943.8221.7314.8739.7121.0425.01--
Shanghai Haixin Group Co Ltd1.11bn171.70m5.23bn760.0040.781.77--4.710.14220.14220.91853.270.22467.199.321,458,849.004.052.684.573.0646.3744.5518.0211.172.83--0.008936.10-17.881.481.204.19-10.2713.18
HitGen Inc409.13m64.05m5.24bn452.0082.093.80--12.810.15930.15931.023.440.2416.704.84905,165.503.774.634.025.1051.4658.8915.6620.6614.48360.770.14219.1412.6419.6961.16-1.96-6.12--
Hunan Fangsheng Pharmaceutical Co Ltd1.63bn193.23m5.29bn1.69k27.173.44--3.240.44280.44283.723.490.52271.486.56966,866.905.935.399.729.3767.7566.9111.348.950.552716.410.344746.47-9.129.15-34.6420.6823.914.75
Shanghai Hile Bio-Technology Co Ltd239.79m44.92m5.31bn295.00120.634.25--22.140.06690.06690.36641.900.1541.062.40812,857.502.061.732.562.4745.1950.4413.3710.371.16--0.056223.89-19.76-1.11-48.3024.17-41.3223.47
InventisBio Co Ltd194.13m-249.28m5.42bn221.00--2.80--27.92-0.4289-0.42890.33483.350.0898--1.96878,429.50-11.53---12.26--97.85---128.41------0.0054------41.26------
Innovita Biological Technology Co Ltd625.12m266.22m5.52bn404.0020.752.78--8.831.961.964.5914.620.30931.676.231,547,324.0013.17--14.20--80.99--42.59--10.66--0.0015--7.03--15.44------
Data as of May 17 2024. Currency figures normalised to HitGen Inc's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

1.01%Per cent of shares held by top holders
HolderShares% Held
Da Cheng Fund Management Co., Ltd.as of 30 Jun 20231.67m0.42%
Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 20231.04m0.26%
China Merchants Fund Management Co., Ltd.as of 30 Jun 2023521.17k0.13%
First-Trust Fund Management Co., Ltd.as of 30 Jun 2023415.37k0.10%
E Fund Management Co., Ltd.as of 30 Jun 2023153.55k0.04%
SSgA Funds Management, Inc.as of 04 Apr 2024114.25k0.03%
HFT Investment Management Co., Ltd.as of 30 Jun 2023107.87k0.03%
Harvest Fund Management Co., Ltd.as of 30 Jun 20236.00k0.00%
GF Fund Management Co., Ltd.as of 30 Jun 20233.90k0.00%
China Universal Asset Management Co., Ltd.as of 30 Jun 2023824.000.00%
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.